HeartEpoch

HeartEpoch, founded in 2022 and headquartered in Zhangjiang, Shanghai, focuses on the innovation and development of heart valve products. It is committed to breaking through the treatment bottlenecks of valvular heart diseases, providing safer, more efficient, and more economical medical solutions for patients with valvular diseases globally. Adhering to the concept of combining technological innovation with clinical needs, HeartEpoch has launched a groundbreaking polymer valve product that effectively integrates the advantages of mechanical and biological valves. This product offers benefits such as a long service life, zero calcification, low thrombogenicity, and high biocompatibility, while significantly reducing treatment costs. This innovative product also has the potential to address the issue of Chinese valve companies' reliance on imported leaflet materials, further promoting the development of China's medical device industry.